Drug major AstraZeneca commits $71 mn to Meghalaya's forestry project

About 200,000 trees have already been planted and with the official project launch, soil and water conservation work is underway to enable further planting of millions of trees in 2024

AstraZeneca
Photo: Bloomberg
Press Trust of India Mumbai
3 min read Last Updated : Dec 04 2023 | 10:37 PM IST

European drug major AstraZeneca has announced a USD 71 million funding to plant and maintain an estimated 64 million plants and trees in the country, primarily in the ecologically fragile Meghalaya.

The funding is part of its global forest programme, under which it has committed to plant 200 million trees across six continents by 2030, the company said in a statement on Monday.

The company will implement the restoration programme in collaboration with Earthbanc, Earthtree, Worldview Impact India and the Hill Farmers Shiitake Mushroom Coop Society on the Meghalaya Reforestation and Sustainable Livelihoods Project called the Regeneration Meghalaya -- a 30-year regenerative horticulture and agriculture project in the northeastern state.

About 200,000 trees have already been planted and with the official project launch, soil and water conservation work is underway to enable further planting of millions of trees in 2024.

The project aims to help Meghalayan farmers restore 22,670 hectares in the state, supporting biodiversity and soil conservation, as well as climate and catchment health co-benefits.

The other benefits include helping farmers do sustainable farming and agroforestry with non-timber commodities, including essential oils and food that align with the Meghalaya aromatics policy, and crop management that aligns with the organic and natural farming policy.

Biophysical indicators such as biomass, soil organic carbon, land productivity and land cover will be monitored, in alignment with the UNCCD land degradation neutrality global mechanism, of which the government of India is a key signatory.

The project will be the largest in a network of the Circular Bioeconomy Alliance's (CBA) "living labs for nature, people and planet".

These connected initiatives follow a science-based framework for sustainable, resilient and locally appropriate landscape regeneration co-developed by the European Forest Institute, the CBA and AstraZeneca, said Juliette White, a vice-president for global sustainability at AstraZeneca.

"As part of our commitment to plant and maintain 200 million trees by 2030, in India, our collaboration with Earthbanc will restore nature in a degraded biodiversity hotspot while supporting farming livelihoods," she added.

According to Tom Duncan, the chief executive of Earthbanc, Meghalaya in particular and India in general have impressive policies and programmes.

The project's strong focus on developing sustainable value chains that ensure farmers' livelihoods will also mean land degradation stops as land cover, productivity and soil organic carbon all increase, Louise Baker, Managing Director of the global mechanism of the UN Convention to Combat Desertification, said.

Alex Ellis, the British high commissioner to India, said protecting, restoring, and sustainably managing nature is an important element of India's ambitious carbon sink target and was a priority for England at the COP28 climate summit in Dubai.

Addressing climate change requires action from us all, everywhere, from companies to governments to citizens.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :AstraZenecaMeghalaya

First Published: Dec 04 2023 | 10:35 PM IST

Next Story